Literature DB >> 2546420

Sensitivity and detection efficiency of the peroxidase antiperoxidase (PAP), avidin-biotin peroxidase complex (ABC), and peroxidase-labeled avidin-biotin (LAB) methods.

J M Elias1, M Margiotta, D Gaborc.   

Abstract

The authors have examined the sensitivity and detection efficiency of the three peroxidase methods that currently have the widest application in diagnostic immunohistochemistry: the peroxidase-antiperoxidase (PAP), the avidin-biotin complex (ABC), and the labeled avidin-biotin (LAB) methods. Sensitivity was evaluated by determining the highest useful dilution of polyclonal antiglucagon antibodies applied to formalin-fixed, paraffin-embedded human pancreas. Detection efficiency was evaluated by tabulation of the total number of positive (three or more positive cells) islets. On direct comparison, the LAB method exceeded the PAP and ABC methods in both sensitivity and detection efficiency, which were essentially equal. Titration of linking antiserum of the PAP method boosted its sensitivity and detection efficiency above that of ABC; the PAP had equal sensitivity to the LAB and exceeded it in detection efficiency. The authors conclude that comparisons of immunohistologic methods are meaningful only if both sensitivity and efficiency are considered along with the unique requirements of any single method.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2546420     DOI: 10.1093/ajcp/92.1.62

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  20 in total

1.  Decorin is produced by capillary endothelial cells in inflammation-associated angiogenesis.

Authors:  L Nelimarkka; H Salminen; T Kuopio; S Nikkari; T Ekfors; J Laine; L Pelliniemi; H Järveläinen
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

2.  Immunodiagnosis of childhood malignancies.

Authors:  D M Parham; H Holt
Journal:  Mol Biotechnol       Date:  1999-09       Impact factor: 2.695

3.  Molecular effect of human umbilical cord blood CD34-positive and CD34-negative stem cells and their conjugate in azoospermic mice.

Authors:  Somia H Abd Allah; Heba F Pasha; Abeer A Abdelrahman; Nehad F Mazen
Journal:  Mol Cell Biochem       Date:  2017-01-24       Impact factor: 3.396

4.  Overexpression of membrane-type 2 matrix metalloproteinase induced by hypoxia-inducible factor-1α in pancreatic cancer: Implications for tumor progression and prognosis.

Authors:  Shi-Kai Zhu; Yu Zhou; Chao Cheng; Shan Zhong; Han-Qing Wu; Bo Wang; Ping Fan; Jiong-Xin Xiong; Hong-Ji Yang; He-Shui Wu
Journal:  Mol Clin Oncol       Date:  2014-07-09

5.  Quantitative DNA methylation analysis of paired box gene 1 and LIM homeobox transcription factor 1 α genes in cervical cancer.

Authors:  Ling Xu; Jun Xu; Zheng Hu; Baohua Yang; Lifeng Wang; Xiao Lin; Ziyin Xia; Zhiling Zhang; Yunheng Zhu
Journal:  Oncol Lett       Date:  2018-01-26       Impact factor: 2.967

6.  Osteopetrosis in Src-deficient mice is due to an autonomous defect of osteoclasts.

Authors:  C Lowe; T Yoneda; B F Boyce; H Chen; G R Mundy; P Soriano
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

7.  Immunohistochemistry as an important tool in biomarkers detection and clinical practice.

Authors:  Leandro Luongo de Matos; Damila Cristina Trufelli; Maria Graciela Luongo de Matos; Maria Aparecida da Silva Pinhal
Journal:  Biomark Insights       Date:  2010-02-09

8.  Estrogen receptors, progesterone receptors, and cell proliferation in human breast cancer.

Authors:  M A Fanelli; L M Vargas-Roig; F E Gago; O Tello; R Lucero De Angelis; D R Ciocca
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

9.  The ER-positive/PgR-negative breast cancer phenotype is not associated with mutations within the DNA binding domain.

Authors:  S A Fuqua; D C Allred; R M Elledge; S L Krieg; M G Benedix; Z Nawaz; B W O'Malley; G L Greene; W L McGuire
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

10.  Measurement of steroid hormone receptors in breast cancer patients on tamoxifen.

Authors:  C A Encarnación; D R Ciocca; W L McGuire; G M Clark; S A Fuqua; C K Osborne
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.